Get the Stockscreener App
34.24
3.29%
1.09
Grail Inc stock is traded at $34.24, with a volume of 637.71K.
It is up +3.29% in the last 24 hours and down -7.86% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$33.15
Open:
$33.41
24h Volume:
637.71K
Relative Volume:
0.53
Market Cap:
$1.23B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-0.5656
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
+5.58%
1M Performance:
-7.86%
6M Performance:
-15.93%
1Y Performance:
+107.01%
1-Day Range:
$32.66
$35.29
1-Week Range:
$29.95
$35.29
52-Week Range:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
34.24 | 1.18B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
Insiders At GRAIL Sold US$10m In Stock, Alluding To Potential Weakness - 富途牛牛
Grail reports Q2 EPS ($3.18), consensus ($3.56) - MSN
Grail Inc’s Galleri Test Faces Uncertainty Amid Regulatory Challenges and Rising Competition - MSN
Cizzle Biotechnology Launches CIZ1B Biomarker Test in the US - AInvest
Grail posts latest trial data for Galleri cancer detection test - msn.com
GRAIL’s Improved Q2 Results and Lower Impairments Might Change the Case for Investing in GRAL - simplywall.st
Grail Inc’s Earnings Call Highlights Growth and Optimism - MSN
GRAIL, Inc. (NASDAQ: GRAL): Liquid Biopsy Breakthrough Drives Investor Optimism and Price Target Hike to $40.50 - AInvest
GRAIL, Inc. (NASDAQ:GRAL) Released Earnings Last Week And Analysts Lifted Their Price Target To US$40.50 - Yahoo Finance
Grail Inc's Galleri Test Faces Regulatory Uncertainty Amid Rising Competition - AInvest
GRAIL Reports Growth in Galleri Test Revenue - MSN
Grail updates 2025 cash burn guidance to $310M amid rising Galleri test adoption and expanded partnerships - MSN
Prospect Ridge Resources Completes Knauss Creek and Holy Grail Exploration; Launches Castle and Excalibur Copper-Gold Porphyry Programs - Junior Mining Network
GRAIL Inc Reports 11% Revenue Growth, Establishes Strategic Partnerships and Expands Galleri Test Availability - AInvest
GRAIL Inc's Strong Growth and Strategic Advancements Affirm Buy Rating - AInvest
Can GRAIL LLC navigate macro headwindsQuick Profit Opportunity Radar - thegnnews.com
What GRAIL (GRAL)'s Sharply Narrowed Losses and Lower Charges Mean for Shareholders - simplywall.st
GRAIL Inc (GRAL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
GRAIL to Announce Second Quarter 2025 Financial Results - Eastern Progress
Grail's Q2 2025 Earnings: A Strategic Inflection Point for Multi-Cancer Early Detection (MCED) - AInvest
GRAIL's 2025 Q2 Earnings Call: Unpacking Contradictions in Cash Burn, International Growth, and Regulatory Pathways - AInvest
GRAIL's Q2 2025 Earnings: A Strategic Pivot Amid Skepticism Positions for Long-Term Value Creation - AInvest
Earnings call transcript: Grail Inc reports Q2 2025 earnings beat, stock rises - Investing.com
Grail Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Grail Q2 Loss Narrows, Revenue Increases to $35.5M - AInvest
GRAIL Q2 Loss Narrows, Revenue Ticks Up - MarketScreener
Grail shares fall as revenue misses estimates despite narrower loss By Investing.com - Investing.com South Africa
Grail shares fall as revenue misses estimates despite narrower loss - Investing.com
GRAIL Inc. Q2 Earnings: Revenue Misses Expectations, EPS Beats - AInvest
GRAIL Reports Second Quarter 2025 Financial Results - TradingView
Earnings Flash (GRAL) GRAIL, Inc. Reports Q2 Revenue $35.5M, vs. FactSet Est of $36.9M - MarketScreener
Grail Inc options imply 12.6% move in share price post-earnings - TipRanks
Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 - Yahoo Finance
8 Stocks Jeff Bezos Is Buying - US News Money
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics
How strong is GRAIL LLC company’s balance sheetUnlock steady growth with low-risk stocks - Jammu Links News
Is it the right time to buy GRAIL LLC stockHigh-yield capital appreciation - Jammu Links News
What is GRAIL LLC company’s growth strategyUnprecedented market success - Jammu Links News
What makes GRAIL LLC stock price move sharplyMaximize your portfolio’s growth with expert tips - Jammu Links News
Why is GRAIL LLC stock attracting strong analyst attentionInvest with confidence backed by data - Jammu Links News
How volatile is GRAIL LLC stock compared to the marketRetirement Planning Review With Proven Results - jammulinksnews.com
Commit To Purchase Grail At $20, Earn 21.5% Using Options - Nasdaq
Early Cancer Detection Pioneer GRAIL Reveals Latest Innovations at Canaccord Growth Conference - Stock Titan
What analysts say about GRAIL LLC stock outlookAI Based High Gain Watchlist Scanner Shared - beatles.ru
Drawdown in GRAIL LLC May Be Nearing EndFast Gaining Stock Screener Reports Released - beatles.ru
GRAIL LLC Shows Risk Reward Favoring UpsideAI Screening for Swing Trade Picks Finds Momentum - metal.it
GRAIL Announces Q2 2025 Financial Results and Upcoming Webcast and Conference Call - AInvest
Cancer Detection Pioneer GRAIL Sets Q2 Earnings Call: Key Details for Healthcare Investors - Stock Titan
When is the best time to buy GRAIL LLC stockWeekly Stock Watch With Growth Focus Expanded - beatles.ru
What markets is GRAIL LLC expanding into Is Cadiz Inc. stock a good long term investment optionDiscover high-impact stocks for your portfolio - Jammu Links News
What institutional investors are buying GRAIL LLC stockRapid portfolio appreciation - jammulinksnews.com
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Grail Inc Stock (GRAL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Freidin Aaron | Chief Financial Officer |
Aug 19 '25 |
Sale |
32.02 |
877 |
28,082 |
285,143 |
4.05%
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):